Doctor profile · Federal record
Dr. Anna Gramling, MD
Rheumatology Physician (CMS: Rheumatology) · Indianapolis, IN
- NPI 1508033408
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
6820 Parkdale Pl
Indianapolis, IN 462546601
(317) 944-1000
fax (317) 328-6601 - Additional location
-
1100 Southfield Dr, Suite 1330
Plainfield, IN 461684498
(317) 837-5510
fax (317) 837-5520 - Mailing address
-
250 N Shadeland Ave
Indianapolis, IN 462194959
Credentials & registration
- NPI registered
- May 2008 — 18 yrs on file
- Profile last updated
- March 4, 2026
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Indiana #01072820A
- Medicaid
- IN #201171600
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1508033408. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,141
Distinct HCPCS
6
Medicare allowed
$72,987
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,800 | 20 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 188 | 112 | $119 | |
96372 |
Injection of drug or substance under skin or into muscle | 49 | 21 | $13 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 49 | 49 | $155 | |
J1030 |
Injection, methylprednisolone acetate, 40 mg | 32 | 15 | $8 | |
20610 |
Aspiration and/or injection of fluid from large joint | 23 | 16 | $64 |
In context: peer comparison
Among 17 peers in Indianapolis Rheumatology Physician, average services per provider: 1,563. This provider delivers 1.4× the peer median.Open Payments
Industry payments received
All-time total
$2,434
Transactions
165
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 31 | $439.36 | |
| Janssen Biotech, INC. | 15 | $435.30 | |
| Abbvie INC. | 40 | $407.25 | |
| Pfizer INC. | 38 | $371.11 | |
| Novartis Pharmaceuticals Corporation | 10 | $147.39 | |
| AstraZeneca Pharmaceuticals Lp | 6 | $115.22 | |
| Genzyme Corporation | 4 | $90.86 | |
| Ucb, INC. | 4 | $79.35 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $77.89 | |
| Lilly USA, LLC | 4 | $73.12 | |
| Mallinckrodt Hospital Products INC. | 2 | $37.67 | |
| GlaxoSmithKline, LLC. | 2 | $35.40 | |
| Alexion Pharmaceuticals, INC. | 2 | $33.92 | |
| Genentech USA, INC. | 2 | $31.34 | |
| Argenx US, INC. | 1 | $25.69 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,370
Patients
319
Total drug cost
$1,508,293
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 324 | 75 | $8,736 |
| Hydroxychloroquine Sulfate | Generic | 247 | 63 | $15,280 |
| Prednisone | Generic | 180 | 67 | $1,293 |
| Folic Acid | Generic | 84 | 21 | $371 |
| Allopurinol | Generic | 83 | 18 | $2,000 |
| Enbrel Sureclick (Etanercept) | Brand | 79 | 13 | $660,293 |
| Tramadol Hcl | Generic | 70 | 15 | $504 |
| Leflunomide | Generic | 61 | 19 | $2,717 |
| Humira(Cf) Pen (Adalimumab) | Brand | 56 | 0 | $526,421 |
| Gabapentin | Generic | 40 | 12 | $990 |
Hospital affiliations
Frequently asked questions
What is Dr. Anna Gramling's medical specialty?
Dr. Anna Gramling practices Rheumatology Physician in Indianapolis, IN.
Where does Dr. Anna Gramling practice?
Dr. Anna Gramling practices at 6820 Parkdale Pl, Indianapolis, IN 462546601. Office phone: 3179441000.
What is Dr. Anna Gramling's NPI?
Dr. Anna Gramling's National Provider Identifier (NPI) is 1508033408, issued by NPPES.
Does Dr. Anna Gramling accept Medicare assignment?
Dr. Anna Gramling does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Anna Gramling commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Injection of drug or substance under skin or into muscle (HCPCS 96372). Source: CMS Medicare Physician & Other Practitioners file.